CONSUMER HEALTHCARE PRODUCTS ASSOCIATION for CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOLIE BROCHIN | — |
| MARC SCHLOSS | — |
| DAVID CHARLES SPANGLER | — |
Consumer Issues/Safety/Products CSP
- The SHOP SAFE Act - Advocacy to protect funding for the Office of the Intellectual Property Enforcement Coordinator (IPEC) and to advocate for an IPEC appointment before the end of the year. - Proposed legislation on illicit trade for consumer healthcare products
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOLIE BROCHIN | — |
| MARC SCHLOSS | — |
| DAVID CHARLES SPANGLER | — |
Taxation/Internal Revenue Code TAX
- H.R. 1219, Oral Health Products Inclusion Act - S.4587, Dietary Supplements Access Act - H.R.8933, Dietary Supplements Access Act - Pharmaceutical Tariffs - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOLIE BROCHIN | — |
| MARC SCHLOSS | — |
| DAVID CHARLES SPANGLER | — |
Manufacturing MAN
- Pharmaceutical Tariffs
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOLIE BROCHIN | — |
| MARC SCHLOSS | — |
| DAVID CHARLES SPANGLER | — |
Pharmacy PHA
H.R.4958 - GRAS Act S.3122 - Better FDA Act of 2025 H.R. 7291 - GRAS Oversight and Transparency Act H.R. 8385 - Food Labeling Modernization Act of 2026 H.R. 8370 - Dietary Supplement Listing Act of 2026 H.R. 5027 - Ban Harmful Food Dyes Act H.R. 3722 - Do or Dye Act - The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOLIE BROCHIN | — |
| MARC SCHLOSS | — |
| DAVID CHARLES SPANGLER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.